https://www.cmmedia.com.tw/home/articles/28389
聯亞疫苗權利歸屬主體是誰？屬於美國UBI私人公司　而非台灣的聯亞生技？


https://covaxx.reportablenews.com/p...gainst-covid-19
COVAXX, a U.S. biotechnology company and subsidiary of United Biomedical, Inc. (UBI), has announced that the Taiwan Ministry of Health and Welfare on January 29, granted conditional approval to begin Phase 2 trials of UB-612, its vaccine candidate to address the pandemic caused by SARS-CoV-2. COVAXX is developing world’s first multitope peptide-based vaccine against COVID-19, using its high precision, commercially proven and scalable vaccine platform.

COVAXX併入Vaxxinity
之後都會用Vaxxinity這個牌子
https://vaxxinity.com/covid-19-vaccine/